NCT00177554View on ClinicalTrials.gov

Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Non-Hodgkin Lymphoma
Interventions
DRUG

Chemotherapy and Radioimmunotherapy

CHOP-R x 3 cycles followed by zevalin and extended rituximab

Trial Locations (1)

15232

UPMC Cancer Centers, Pittsburgh

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

University of Pittsburgh

OTHER